# enParticle Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/enparticle-co

- Industry: Biotechnology
- Headquarters: Busan, South Korea
- Website: www.enparticle.com/
- Total disclosed funding: $3.2M
- Latest round: Series A (Nov 25, 2024)
- Investors on record: 3

## About

Based in Busan, South Korea, founded in 2018 by co-founder Jungsang Goh, enParticle Co., Ltd. specialises in advanced microfluidic technologies for drug delivery systems for pharmaceutical and cosmetic formulations. In November 2024, enParticle raised KRW 4.5 billion in Series A funding led by investor KB Investment, with participation from investors Korea Investment Partners and Rising S Ventures.

enParticle offers advanced microfluidic technologies for the formulation and mass production of drug delivery systems (DDS) for pharmaceuticals and cosmetics. The primary product offerings include enCELL Master, enCELL Pharm, and enCELL Scale-Up, microfluidic formulation machines to produce lipid nanoparticles (LNPs), liposomes, and polymeric vesicles, which are critical in the development of innovative pharmaceuticals and cosmetic formulations. The enCell device facilitates the production of mRNA vaccines by ensuring uniformity and yields in particle size and chemical homogeneity. The company provides contract development and manufacturing services to assist pharmaceutical companies in accelerating development timelines. These products primarily serve pharmaceutical companies, biotechnology firms, and cosmetic manufacturers in markets such as North America, Europe, and Asia.


The company will use the November 2024 funding to start extensive commercialisation with collaborators in the pharmaceutical and cosmetics sectors.

## Funding rounds

- Series A, Nov 25, 2024, $3.2M — KB Investment, Korea Investment Partners, Rising S Ventures

## Investors

- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A
- Korea Investment Partners (https://capitalatlas.ai/funds/korea-investment-partners) — Series A
- Rising S Ventures (https://capitalatlas.ai/funds/rising-s-ventures) — Series A